| 000 | 01848 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517001327.0 | ||
| 264 | 0 | _c20150522 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1939-327X | ||
| 024 | 7 |
_a10.2337/db14-0667 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan de Weijer, Tineke | |
| 245 | 0 | 0 |
_aEvidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. _h[electronic resource] |
| 260 |
_bDiabetes _cApr 2015 |
||
| 300 |
_a1193-201 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aInsulin Resistance _xphysiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitochondria, Muscle _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 700 | 1 | _aPhielix, Esther | |
| 700 | 1 | _aBilet, Lena | |
| 700 | 1 | _aWilliams, Evan G | |
| 700 | 1 | _aRopelle, Eduardo R | |
| 700 | 1 | _aBierwagen, Alessandra | |
| 700 | 1 | _aLivingstone, Roshan | |
| 700 | 1 | _aNowotny, Peter | |
| 700 | 1 | _aSparks, Lauren M | |
| 700 | 1 | _aPaglialunga, Sabina | |
| 700 | 1 | _aSzendroedi, Julia | |
| 700 | 1 | _aHavekes, Bas | |
| 700 | 1 | _aMoullan, Norman | |
| 700 | 1 | _aPirinen, Eija | |
| 700 | 1 | _aHwang, Jong-Hee | |
| 700 | 1 | _aSchrauwen-Hinderling, Vera B | |
| 700 | 1 | _aHesselink, Matthijs K C | |
| 700 | 1 | _aAuwerx, Johan | |
| 700 | 1 | _aRoden, Michael | |
| 700 | 1 | _aSchrauwen, Patrick | |
| 773 | 0 |
_tDiabetes _gvol. 64 _gno. 4 _gp. 1193-201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/db14-0667 _zAvailable from publisher's website |
| 999 |
_c24313035 _d24313035 |
||